Being denied urgent treatment
I am currently dealing with an extremely frustrating and concerning situation with Transcarent regarding access to a prescribed cancer medication.
For over week and a half I have been trying to obtain Olaparib (Lynparza), a time-sensitive oncology treatment prescribed by my doctor. Instead of receiving support, I have encountered repeated delays, lack of clear communication, and no meaningful resolution.
Most recently, I was told my plan will only allow a 14-day supply. However, the dispensing pharmacy has confirmed they cannot provide a partial fill due to manufacturer packaging restrictions. This effectively leaves me without access to my medication.
I have attempted to escalate this through Transcarent, including speaking with a supervisor, but was not provided access to any clinical team or decision-maker. Despite the urgency of cancer treatment, there has been no accountability or resolution.
This is not just an inconvenience — it is a serious patient care issue. Delays in medically necessary cancer treatment due to administrative barriers should never happen.
I am sharing this to raise awareness and in hopes that Transcarent will take immediate action to resolve situations like this for patients who depend on timely access to critical medications.







